...
首页> 外文期刊>Tropical Journal of Pharmaceutical Research >Effect of albumin administration on post-operation mortality, duration on ventilator, and hospital stay on patients in cardiac intensive care: An observational study
【24h】

Effect of albumin administration on post-operation mortality, duration on ventilator, and hospital stay on patients in cardiac intensive care: An observational study

机译:观察性研究对心脏重症监护患者服用白蛋白对术后死亡率,呼吸机持续时间和住院时间的影响

获取原文
           

摘要

Purpose: To justify the use of albumin infusion in patients in post-surgery cardiac intensive care unit. Methods: All patients who were hemodynamically stable before the operation and admitted into the surgical intensive care unit following coronary artery bypass, cardiopulmonary bypass, or aortic surgery, had no excessive postoperative bleeding and not on diuretic treatment, were included in the analysis. A total of 1998 patients were divided into two cohorts, viz, the first group was placed on albumin infusion (n = 999) while the second group received normal saline infusion (n = 999). Data were obtained from DICOM files of patients and records of pharmacy. Wilcoxon test or two-tailed paired t-test followed by Tukey post-hoc tests were performed for statistical analysis at 95 % of confidence level. Results: Albumin and normal saline administration did not decrease the duration of mechanical ventilation, incidence of mechanical ventilation, need for blood transfusion, and length of hospital stay (p 0.05). Albumin infusion decreased the need for fresh frozen plasma transfusion from 85 to 67, reduced mortality (p = 0.0005, q = 3.959), lowered serum lactate level (p 0.0001, q = 43.853), but increased cardiac index (p 0.0001, q = 12.192) as well as financial burden (p 0.0001, q = 95.158) for the patients, compared to normal saline group. Conclusion: In view of the foregoing, it is recommended that the use of restriction of albumin resuscitation in surgical intensive care unit should be restricted in this subset of patients evluated in this study.
机译:目的:证明在术后心脏重症监护室使用白蛋白输注是合理的。方法:将所有术前血流动力学稳定且在冠状动脉搭桥,心肺搭桥或主动脉手术后入院的外科重症监护室,术后无过多出血且未接受利尿剂治疗的患者纳入分析。将1998年的患者分为两组,第一组接受白蛋白输注(n = 999),第二组接受生理盐水输注(n = 999)。数据来自患者的DICOM文件和药房记录。在95%的置信水平下进行了Wilcoxon检验或两尾配对t检验,然后进行了Tukey post-hoc检验以进行统计分析。结果:白蛋白和生理盐水的施用不会减少机械通气的持续时间,机械通气的发生率,输血的需要以及住院时间(p> 0.05)。输注白蛋白将新鲜冷冻血浆输注的需求从85减少到67,降低了死亡率(p = 0.0005,q = 3.959),降低了血清乳酸水平(p <0.0001,q = 43.853),但心脏指数增加了(p <0.0001,与生理盐水组相比,患者的q = 12.192)和财务负担(p <0.0001,q = 95.158)。结论:鉴于上述情况,建议在本研究中评估的这一部分患者中,应限制在外科重症监护病房中使用白蛋白复苏。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号